Realizing the potential of long non-coding RNAs to develop transformative medicines
NextRNA is uniquely positioned to deliver transformative small molecule therapeutics targeting long non-coding RNAs (lncRNAs).
lncRNAs, a vast class of targets
Proprietary platform and unique capabilities
Small molecule development
NextRNA Therapeutics
DevelopING Transformative Medicines
Developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases
lncRNAs represent a vast class of therapeutic targets that recruit RNA-binding proteins (RBPs) to drive pathological processes across diseases. NextRNA’s unique therapeutic approach is to inhibit the function of lncRNAs by disrupting the interaction between lncRNAs and RBPs with small molecules.
Proprietary platform and unique capabilities to
realize the therapeutic potential of lncRNAs
Become a NextR
Our team is driven by a common passion to advance pioneering science that impacts patients.